Neoleukin Therapeutics - Stock Price History | NLTX

Historical daily share price chart and data for Neoleukin Therapeutics since 2021 adjusted for splits. The latest closing stock price for Neoleukin Therapeutics as of September 27, 2021 is 7.70.
  • The all-time high Neoleukin Therapeutics stock closing price was 22.13 on August 14, 2015.
  • The Neoleukin Therapeutics 52-week high stock price is 17.95, which is 133.1% above the current share price.
  • The Neoleukin Therapeutics 52-week low stock price is 5.95, which is 22.7% below the current share price.
  • The average Neoleukin Therapeutics stock price for the last 52 weeks is 10.95.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Neoleukin Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 11.9209 11.8500 17.0500 6.1200 14.1000 14.45%
2019 3.2938 2.3300 12.7200 2.2300 12.3200 470.37%
2018 8.0299 12.0000 16.5500 2.0700 2.1600 -81.63%
2017 14.4732 16.2000 19.7600 10.0800 11.7600 -28.77%
2016 10.2919 12.3300 17.7700 6.1600 16.5100 32.29%
2015 10.6295 7.6300 22.1300 1.4600 12.4800 66.40%
2014 8.5089 11.9500 14.0000 5.6100 7.5000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.327B $0.025B
Neoleukin Therapeutics Inc. is a biopharmaceutical company. It is engaged in creating next generation immunotherapies using de novo protein design technology. The company's product candidate consists of NL-201 which is in clinical stage. Neoleukin Therapeutics Inc., formerly known as Aquinox Pharmaceuticals Inc., is based in Seattle, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29